Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Alzheimer's Disease

Free Subscription Articles published in Lancet Retrieve available abstracts of 10 articles: HTML format

Single Articles

March 2026
1. CUMMINGS JL, Atri A, Sano M, Zetterberg H, et al
   Efficacy and safety of oral semaglutide 14 mg (flexible dose) in early-stage symptomatic Alzheimer's disease (evoke and evoke+): two phase 3, randomised, placebo-controlled trials.
   Lancet. 2026 Mar 19:S0140-6736(26)00459-9. doi: 10.1016/S0140-6736(26)00459.
   PubMed     Abstract available
   
   
   
2. SCHNEIDER LS
   Semaglutide for Alzheimer's disease after evoke and evoke.
   Lancet. 2026 Mar 19:S0140-6736(26)00514-3. doi: 10.1016/S0140-6736(26)00514.
   PubMed    
   
   
   September 2025
3. FRISONI GB, Aho E, Brayne C, Ciccarelli O, et al
   Alzheimer's disease outlook: controversies and future directions.
   Lancet. 2025;406:1424-1442.
   PubMed     Abstract available
   
   
   
4. FOX NC, Belder C, Ballard C, Kales HC, et al
   Treatment for Alzheimer's disease.
   Lancet. 2025;406:1408-1423.
   PubMed     Abstract available
   
   
   
5. FRISONI GB, Hansson O, Nichols E, Garibotto V, et al
   New landscape of the diagnosis of Alzheimer's disease.
   Lancet. 2025;406:1389-1407.
   PubMed     Abstract available
   
   
   
6. THE LANCET
   Alzheimer's disease: are health systems ready?
   Lancet. 2025;406:1313.
   PubMed    
   
   
   May 2025
7. FORTEA J, Boban M, Engelborghs S, Frederiksen KS, et al
   Regulatory asymmetry in Alzheimer's disease care.
   Lancet. 2025 May 14:S0140-6736(25)00907-9. doi: 10.1016/S0140-6736(25)00907.
   PubMed    
   
   
   March 2025
8. ELIA-ZUDAIRE O, Tirado-Galindo M
   Towards a European imaging infrastructure for Alzheimer's disease.
   Lancet. 2025;405:779.
   PubMed    
   
   
   November 2024
9. JESSEN F, Frolich L, Hort J, Winblad B, et al
   Amyloid-lowering treatment in Alzheimer's disease.
   Lancet. 2024 Nov 14:S0140-6736(24)02510-8. doi: 10.1016/S0140-6736(24)02510.
   PubMed    
   
   
   
10. HENEKA MT, Morgan D, Jessen F
    Passive anti-amyloid beta immunotherapy in Alzheimer's disease-opportunities and challenges.
    Lancet. 2024 Nov 13:S0140-6736(24)01883-X. doi: 10.1016/S0140-6736(24)01883.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum